Soheila Ghasri, Eugenie Evelynne Johnson, Bethan Molly Harris, Imogen Forsythe, Claire Eastaugh, Adetutu Sadiq, Nick Meader, Matthew Breckons, Fiona Pearson
{"title":"Barriers and facilitators to using self-sampled tests for the human papillomavirus (HPV): a mixed-methods study to inform a horizon scan.","authors":"Soheila Ghasri, Eugenie Evelynne Johnson, Bethan Molly Harris, Imogen Forsythe, Claire Eastaugh, Adetutu Sadiq, Nick Meader, Matthew Breckons, Fiona Pearson","doi":"10.1017/S0266462326103729","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Human papillomavirus (HPV), particularly high-risk types such as HPV 16 and 18, is a major cause of cervical cancer and other cancers. Despite the United Kingdom's (UK's) commitment to cervical cancer elimination by 2040, participation in HPV screening is declining, disproportionately affecting underserved groups, including those experiencing poverty, people from minoritized racial, ethnic, gender, or sexual identity groups, and people living with HIV.</p><p><strong>Methods: </strong>We conducted a mixed-methods study to explore awareness, barriers, and facilitators to HPV self-sampling from clinician and public perspectives. A multi-stakeholder survey (<i>n</i> = 105) and two online focus groups with clinicians (<i>n</i> = 4) and members of the public (<i>n</i> = 5) were undertaken.</p><p><strong>Results: </strong>Survey respondents identified accuracy, cost-free availability, ease of use, accessibility, clear instructions, and adequate follow-up as critical test features. Participants emphasized that disability, cultural context, language, and socioeconomic status strongly influence barriers and facilitators to uptake. Focus groups provided contextual depth, illustrating how privacy, logistical and emotional impacts, and supportive follow-up pathways shaped acceptability and trust. Clinicians highlighted the need for integration into healthcare infrastructure to maintain trust and ensure support. Public participants recommended community-driven engagement, including multilingual instructions and tailored communication to encourage adoption among diverse groups. Concerns were raised about unintended consequences, such as anxiety following asymptomatic HPV diagnoses and challenges in managing clinical pathways after positive results. Suggestions included leveraging community organizations to reduce hesitancy.</p><p><strong>Conclusions: </strong>Findings highlight policy and implementation considerations for embedding HPV self-sampling within care pathways to improve uptake and reduce inequalities.</p>","PeriodicalId":14467,"journal":{"name":"International Journal of Technology Assessment in Health Care","volume":" ","pages":"e46"},"PeriodicalIF":3.0000,"publicationDate":"2026-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13161927/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Technology Assessment in Health Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/S0266462326103729","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Human papillomavirus (HPV), particularly high-risk types such as HPV 16 and 18, is a major cause of cervical cancer and other cancers. Despite the United Kingdom's (UK's) commitment to cervical cancer elimination by 2040, participation in HPV screening is declining, disproportionately affecting underserved groups, including those experiencing poverty, people from minoritized racial, ethnic, gender, or sexual identity groups, and people living with HIV.
Methods: We conducted a mixed-methods study to explore awareness, barriers, and facilitators to HPV self-sampling from clinician and public perspectives. A multi-stakeholder survey (n = 105) and two online focus groups with clinicians (n = 4) and members of the public (n = 5) were undertaken.
Results: Survey respondents identified accuracy, cost-free availability, ease of use, accessibility, clear instructions, and adequate follow-up as critical test features. Participants emphasized that disability, cultural context, language, and socioeconomic status strongly influence barriers and facilitators to uptake. Focus groups provided contextual depth, illustrating how privacy, logistical and emotional impacts, and supportive follow-up pathways shaped acceptability and trust. Clinicians highlighted the need for integration into healthcare infrastructure to maintain trust and ensure support. Public participants recommended community-driven engagement, including multilingual instructions and tailored communication to encourage adoption among diverse groups. Concerns were raised about unintended consequences, such as anxiety following asymptomatic HPV diagnoses and challenges in managing clinical pathways after positive results. Suggestions included leveraging community organizations to reduce hesitancy.
Conclusions: Findings highlight policy and implementation considerations for embedding HPV self-sampling within care pathways to improve uptake and reduce inequalities.
期刊介绍:
International Journal of Technology Assessment in Health Care serves as a forum for the wide range of health policy makers and professionals interested in the economic, social, ethical, medical and public health implications of health technology. It covers the development, evaluation, diffusion and use of health technology, as well as its impact on the organization and management of health care systems and public health. In addition to general essays and research reports, regular columns on technology assessment reports and thematic sections are published.